EUCTR2013-004936-31-NL进行中（未招募）1 期
Establish limits for fitness to drive with prolonged use of ICADTS class III medication
Ministry of Infrastructure and the Environment0 个研究点开始时间: 2014年1月20日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients: chronic use of ICADTS class III medication (> 6 months)
- •- age between 21 and 75 (inclusive)
- •- BMI between 19 an 29 m2/kg (inclusive)
- •- in posession of a valid drivers license for at least 3 years
- •- driving experience of at least 3000 km/yeat on average
- •- sufficient vision
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 140
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 140
排除标准
- •- a neurological disorder
- •- use of drugs
- •- excessive alcohol consumption (> 21 glasses of alcohol/week)
- •- smoking (> 10 cigarettes/day)
- •- pregnancy
研究者
相似试验
已完成
4 期
Establish limits for fitness to drive with prolonged use of ICADTS class III medicatiodepressieve stemmingsstoornissen - en afwijkingenslaapstoornissen - en afwijkingensleeping problems10002861depressionanxietyNL-OMON41276Ministerie van Volkshuisvesting, Ruimtelijke Ordening en Milieu (VROM)272
招募中
不适用
A new clinical tool to assess fitness-to-drive in obstructive sleep apneaObstructive Sleep ApneaRespiratory - Sleep apnoeaACTRN12619001067167Flinders University100
尚未招募
不适用
An assessment of driving fitness in patients with visual field defect using driving simulatorglaucoma, retinitis pigmentosa, hemianopiaJPRN-UMIN000026794Division of Ophthalmology and Visual Science,Graduate School of Medical and Dental Sciences, Niigata University.200
已完成
2 期
Driving fitness under Silexan compared to placebo and lorazepamISRCTN32209377Dr. Willmar Schwabe GmbH & Co. KG201
进行中（未招募）
1 期
Influence of Silexan® on driving fitnessEUCTR2015-001101-14-DEDr. Willmar Schwabe GmbH & Co. KG72